-
tract. We aim to develop human 3D tissue models that mimic the mucosa lining the airways and the pulmonary alveoli. These models will provide the means to identify the determinants of susceptibility
-
will apply and develop computational tools for the analysis of large data sets generated by short-read, long-read, and single cell DNAseq/RNAseq analyses of cells evolving in vitro in culture and in vivo
-
. Through this project, the applicant will be able to develop their knowledge in genetics, gene regulation, and epigenetics. The project will involve communicating and learning from clinician researchers who
-
-neutralizing and poly-functional antibodies we intend to develop offer promising opportunities to treat and/or prevent human infections. Candidate requirements: Applicants should have a strong background in
-
consortium with over 10 research laboratories and an industrial partner. The IP-Cure-B project includes a pre-clinical platform to develop and test novel immunomodulators targeting HBV, as well as a clinical